The investigation of CNV of the Trx1 gene in the TCGA data revealed that diploid and gain genome variations in the Trx1 gene were significantly associated with less advanced tumor stages and clinicopathological features, while losses were more frequently observed in higher tumor stages and were associated with advanced clinicopathological features (Fig. 2A). The gene discussed is TXN; the disease is neoplasm.